Central Nervous System Pain

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Pain Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Pain Projects
--Allergan Inc
--Abbott Laboratories
--Dov Pharmaceutical Inc
--Cephalon Inc
--Forest Laboratories Inc
--DURECT Corporation
--Grunenthal GmbH
--GlaxoSmithKline plc
--Javelin Pharmaceuticals Inc
--GW Pharmaceuticals PLC
--Merck & Co Inc
--Johnson & Johnson
--Nycomed
--NeuroSearch A/S
--Otsuka Pharmaceutical Co., Ltd.
--Ortho-McNeil, Inc.
--Pharmos Corporation
--Pfizer Inc
--Teikoku Seiyaku Co., Ltd.
--Teikoku Pharma USA, Inc.

--Top Companies in early stage Pain Projects
--Allergan Inc
--Abbott Laboratories
--AstraZeneca Plc
--Amgen Inc
--Cara Therapeutics Inc
--BTG plc
--ExonHit Therapeutics SA
--Evotec AG
--Glenmark Pharmaceuticals Limited
--Futura Medical plc
--Lipocine Inc.
--Lay Line Genomics SpA
--Novavax Inc
--NeurAxon Inc.
--Pharmos Corporation
--Pfizer Inc
--Shimoda Biotech
--Schering-Plough Corp
--VM Discovery, Inc.
--Traxion Therapeutics Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View